SLC7A11
Basic information
Region (hg38): 4:138164097-138242349
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC7A11 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 31 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 31 | 3 | 0 |
Variants in SLC7A11
This is a list of pathogenic ClinVar variants found in the SLC7A11 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-138179253-A-G | not specified | Uncertain significance (Sep 17, 2021) | ||
4-138179273-G-A | not specified | Uncertain significance (Jun 22, 2023) | ||
4-138179295-T-G | not specified | Uncertain significance (Jul 27, 2022) | ||
4-138179298-C-T | not specified | Likely benign (Mar 22, 2023) | ||
4-138179342-G-A | not specified | Uncertain significance (Mar 17, 2023) | ||
4-138180675-C-T | not specified | Uncertain significance (Nov 21, 2022) | ||
4-138180715-G-A | not specified | Uncertain significance (Mar 24, 2023) | ||
4-138180774-A-G | not specified | Uncertain significance (Sep 17, 2021) | ||
4-138182308-C-T | not specified | Uncertain significance (Oct 26, 2022) | ||
4-138182350-G-A | not specified | Uncertain significance (Jul 06, 2021) | ||
4-138183265-A-G | not specified | Uncertain significance (Aug 30, 2021) | ||
4-138185167-G-A | not specified | Uncertain significance (May 31, 2023) | ||
4-138185201-T-C | not specified | Likely benign (Jul 12, 2023) | ||
4-138185237-G-A | not specified | Uncertain significance (Apr 24, 2024) | ||
4-138219347-T-C | not specified | Uncertain significance (Nov 17, 2022) | ||
4-138223282-G-A | not specified | Uncertain significance (Oct 10, 2023) | ||
4-138223292-T-G | not specified | Uncertain significance (May 14, 2024) | ||
4-138223297-C-T | not specified | Uncertain significance (Jun 07, 2024) | ||
4-138232285-T-C | not specified | Uncertain significance (Sep 13, 2023) | ||
4-138232288-G-A | not specified | Uncertain significance (Jan 16, 2024) | ||
4-138232300-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
4-138232327-A-G | not specified | Uncertain significance (May 04, 2023) | ||
4-138232339-T-G | not specified | Uncertain significance (May 14, 2024) | ||
4-138232344-C-T | not specified | Uncertain significance (Oct 18, 2021) | ||
4-138232345-G-A | not specified | Uncertain significance (Oct 06, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC7A11 | protein_coding | protein_coding | ENST00000280612 | 12 | 78253 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000568 | 0.994 | 125709 | 0 | 39 | 125748 | 0.000155 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.779 | 242 | 279 | 0.869 | 0.0000144 | 3215 |
Missense in Polyphen | 92 | 115.04 | 0.79975 | 1382 | ||
Synonymous | -0.131 | 107 | 105 | 1.02 | 0.00000573 | 1046 |
Loss of Function | 2.45 | 11 | 23.9 | 0.460 | 0.00000124 | 287 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000200 | 0.000200 |
Ashkenazi Jewish | 0.0000994 | 0.0000992 |
East Asian | 0.0000546 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000198 | 0.000193 |
Middle Eastern | 0.0000546 | 0.0000544 |
South Asian | 0.000229 | 0.000229 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Sodium-independent, high-affinity exchange of anionic amino acids with high specificity for anionic form of cystine and glutamate. {ECO:0000269|PubMed:15151999}.;
- Pathway
- Ferroptosis - Homo sapiens (human);miR-targeted genes in leukocytes - TarBase;miR-targeted genes in muscle cell - TarBase;Nuclear Receptors Meta-Pathway;NRF2 pathway;Transcriptional activation by NRF2;mRNA, protein, and metabolite inducation pathway by cyclosporin A;Amino acid transport across the plasma membrane;Amino acid and oligopeptide SLC transporters;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Transport of small molecules;Methionine and cysteine metabolism;Cell surface interactions at the vascular wall;Hemostasis;Basigin interactions
(Consensus)
Recessive Scores
- pRec
- 0.195
Intolerance Scores
- loftool
- 0.230
- rvis_EVS
- 0.22
- rvis_percentile_EVS
- 68.38
Haploinsufficiency Scores
- pHI
- 0.212
- hipred
- N
- hipred_score
- 0.393
- ghis
- 0.445
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.677
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc7a11
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; neoplasm; pigmentation phenotype; vision/eye phenotype; immune system phenotype; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); cellular phenotype;
Gene ontology
- Biological process
- amino acid transmembrane transport;glutathione metabolic process;visual learning;response to toxic substance;response to organic cyclic compound;ventricular system development;striatum development;adult behavior;regulation of neutrophil apoptotic process;cellular response to oxidative stress;glutathione transmembrane transport;response to nicotine;regulation of cell population proliferation;regulation of melanin biosynthetic process;lung alveolus development;modulation of chemical synaptic transmission;leukocyte migration;regulation of protein transport;response to redox state;limb development;lens fiber cell differentiation;platelet aggregation;glutamate homeostasis;L-glutamate import across plasma membrane;dipeptide import across plasma membrane;regulation of cysteine metabolic process;negative regulation of oxidative stress-induced neuron death;regulation of glutathione biosynthetic process;regulation of AMPA glutamate receptor clustering;regulation of glutamate metabolic process
- Cellular component
- rough endoplasmic reticulum;cytoskeleton;plasma membrane;cell surface;integral component of membrane;brush border membrane;astrocyte projection
- Molecular function
- protein binding;L-amino acid transmembrane transporter activity;cystine:glutamate antiporter activity